Skip to content
Storm The Heavens Fund

Put an end to DIPG through prayer, research & awareness.

  • Home
  • About DIPG
  • Our Inspiration
  • Our Impact
    • Research
    • Legislation
    • Stories / Prayers
  • Events
    • Sponsors
  • Contact
  • Donate
    Donate

Watch The Video

Our Impact

Storm the Heavens Fund is a community dedicated to creating a world where no child dies from DIPG.

There is no cause greater than the fight for our Children’s right to grow up to be adults.
Donate Today

Funded Research Projects

  • Diffuse Midline Glioma-Adaptive Clinical Trial

    Storm the Heavens Fund has committed $300,000 to support the Diffuse Midline Glioma-Adaptive Clinical Trial (DMG-ACT).
    Learn More
    Diffuse Midline Glioma-Adaptive Clinical Trial
  • The DIPG Collaborative

    Storm the Heavens is a Foundational Partner in the DIPG Collaborative, contributing $87,000 to date with a minimum annual contribution of $25,000.
    Learn More
    The DIPG Collaborative
  • The Philomena DIPG Research Initiative Project

    Storm the Heavens has funded the Philomena DIPG Research Initiative Project in its entirety by granting $322,000 to Dr. Charles Keller at the Children’s Cancer Therapy Development Institute.
    Learn More
    The Philomena DIPG Research Initiative Project
  • Alex’s Lemonade Stand Foundation

    Storm the Heavens Fund donated $25,000 to Alex’s Lemonade Stand Foundation to fund a grant for a DIPG research project at the University of Michigan.
    Learn More
    Alex’s Lemonade Stand Foundation

    Additional Research

    In 2020, Storm the Heavens Fund donated $10,000 to Oncoceutics, a clinical-stage drug discovery and development company.  The donation was to assist in funding an Expanded Access program for ONC201 in the United States.
    Learn More

    Legislation

    Join Our Community

    In Bean’s honor, Storm the Heavens Fund is committed to spreading awareness and funding desperately needed research. We believe, with your help, we can fund a cure that will give every child diagnosed with DIPG the chance to live a full, healthy life. Every child has the right to grow up to be an adult.
    Share a Story or Prayer
    Donate Today
    • Home
    • About DIPG?
    • Our Inspiration
    • Our Impact
    • Events
    • Stories
    • Home
    • About DIPG?
    • Our Inspiration
    • Our Impact
    • Events
    • Stories
    Donate

    Storm the Heavens Fund is a faithful community committed
    to spreading awareness and funding research in order
    to create a world in which no child dies from DIPG.

    Contact

    Storm the Heavens Fund
    2424 York Street. Unit 327
    Philadelphia, PA 19125
    Tax ID: 82-2521813

    Storm the Heavens Fund is a faithful community committed to spreading awareness and funding research in order to create a world in which no child dies from DIPG.

    Copyright © 2020 Storm The Heavens Fund. All rights reserved.
    Powered by VujaDay Creative Digital Agency

    Diffuse Midline Glioma-Adaptive Clinical Trial

    The DMG-ACT team consists of investigators from around the world – scientists and clinical researchers – who all came together to collaborate to find better ways to treat our children, share data in real-time, and assess new therapies in multiple laboratories so that only the best-validated treatments are being moved forward into the clinic. The clinical team is working to develop an adaptive trial that will allow for the opening and closing of treatment arms based on any new information derived from the clinic or the lab. We aim for an agile platform that will allow us to bring exciting discoveries from the laboratory into the clinic quickly. The trial is run through the Pacific Pediatric Neuro-Oncology Consortium (PNOC) — a clinical trial consortium consisting of 19 sites in the United States as well as international sites in Australia, Canada, and Europe.

    Participating locations include:
    • Children’s National Medical Center
    • Children’s Hospital of Philadelphia
    • Dana Farber Cancer Institute
    • John Hopkin’s University
    • University of California San Francisco
    • Seattle Children’s Hospital
    • Diffuse Midline Glioma Center, University Children’s Hospital Zurich
    • Hudson Institute of Medical Research
    • University of Michigan
    The trial has an estimated total cost of over $4 million. Storm the Heavens was one of the first foundations supporting this project.

    The DIPG Collaborative

    In 2018 Storm the Heavens Fund joined the DIPG joined the DIPG Collaborative (http://dipgcollaborative.org/ ), as a Foundational Partner. The DIPG Collaborative was founded in 2011 by The Cure Starts Now (thecurestartsnow.org). The DIPG Collaborative is a cooperative effort of independent foundations from around the world that join together to support long term DIPG research, eliminating duplication, enhancing transparency and building cooperative channels. To date, the DIPG Collaborative has produced three DIPG Collaborative Symposiums featuring experts from over 15 different countries. The Collaborative supported the development of the International DIPG Registry and the SIOPe DIPG Registry and has funded over $11 million in innovative trials. We are helping to find a home run cure for cancer by going after the biggest bully of them all. Storm the Heavens has contributed over $87,000 to the DIPG Collaborative to date and we are committed to increasing our contributions every year.

    The Philomena DIPG Research Initiative Project

    Storm the Heavens is funding a 2-year $322,000 research project lead by research Dr. Charles Keller, MD at the Children's Cancer Therapy Development Institute (cc-tdi.org). The project is being funded 100% by Storm The Heavens Fund. The neurobiologist –biomedical engineering team is focusing their research on “The Tumor Cell Hotel – An implantable device whereby DIPG checks in but does not check out.” The goal is to bait DIPG tumor cells into The Tumor Cell Hotel, a thin film with an attractant “bait” and a sticky “trap” that would be applied by a neurosurgeon through the middle cerebellar peduncle and replaced periodically to remove the DIPG cells. For more information on the Philomena DIPG Research Initiative Project, please visit bit.ly/PhilomenaProject.

    Alex’s Lemonade Stand Foundation

    In 2019 Storm the Heavens Fund has partnered with ALSF to jointly fund innovative research for Diffuse Intrinsic Pontine Glioma (DIPG). Storm the Heavens has contributed $25,000 to ALSF to fund a grant for a DIPG specific project out of the University of Michigan. ALSF has agreed to match those funds, providing a larger impact on innovative therapies for DIPG.

    Additional Research

    In 2020, Storm the Heavens Fund donated $10,000 to Oncoceutics, a clinical-stage drug discovery and development company.  The donation was to assist in funding an Expanded Access program for ONC201 in the United States. ONC201 is an investigational medicine that is being evaluated in Phase I and Phase II trials.

    The program will allow Oncoceutics to work with physicians practicing in the United States to provide ONC201 to patients with H3 K27M-mutant glioma, including DIPG, who meet certain eligibility criteria and who cannot otherwise access ONC201 by participating in an ongoing clinical trial. The Expanded Access program has been made available to select hospitals across the United States,

    For more information:   https://oncoceutics.com/oncoceutics-receives-foundation-grants-to-establish-an-expanded-access-program-for-onc201/